A new study by Intermountain Health researchers finds that peripheral artery disease, a condition that affects more than 10 ...

Peripheral artery disease, also known as PAD, is a condition in which the narrowing of the arteries causes poor blood flow to ...

Luton, Bedfordshire, United Kingdom, May 21, 2025 (GLOBE NEWSWIRE) -- The global angioplasty market for peripheral arterial disease (PAD) is expanding steadily, driven by rising PAD prevalence and ...

The global peripheral vascular devices market, valued at USD 4.7 billion in 2022, is projected to expand at a robust CAGR of 6.6%, reaching USD 8.9 billion by 2032, according to Future Market Insights ...

The diagnosis of diabetes has been widely recognised as a significant risk factor in the development of arteriosclerotic ...

For those who were only vitamin D insufficient—not deficient—insufficiency was associated with a 5% increased risk of total ...

Eight months of supervised marathon training in Finnish adults led to moderate reductions in peripheral diastolic blood ...

Semaglutide increased maximum walking distance by 13% compared with placebo. Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated ...

Within six months, the drug reduced the risk of cardiovascular death by 50% and cut the risk of needing urgent treatment due ...